Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Shire (LSE:SHP; SHPGY) will sell non-core products to Almirall (Barcelona, Spain) for $213
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury